Results 111 to 120 of about 13,636 (200)

Asthma and Multimorbidity Amongst Ethnic Minority Groups in High Income Countries

Clinical &Experimental Allergy, Volume 56, Issue 9, Page 1031-1047, September 2026.
There is a tight intersection between asthma, deprivation, ethnicity, multimorbidity and poor clinical outcomes. An integrated, holistic and culturally tailored approach is needed to improve clinical outcomes amongst ethnic minority groups with asthma and multimorbidity. ABSTRACT Asthma is one of the commonest noncommunicable diseases worldwide.
Mamidipudi Thirumala Krishna, Saibal Moitra, Anna Freeman, Ben Ainsworth, Rebecca Knibb, Ramesh Kurukulaaratchy, Adel H. Mansur   +6 more
wiley   +1 more source

A new era beckons in asthma: enhanced models of care, disease remission, artificial intelligence and consumer participation

Internal Medicine Journal, Volume 56, Issue 9, Page 1649-1653, September 2026.
Abstract The landscape of asthma management is undergoing significant transformation. This change is driven by several factors: deeper understanding of asthma pathophysiology, appreciation of the long‐term harm of oral corticosteroids, biological treatments that dramatically improve patient outcomes with asthma remission becoming a realistic goal, and ...
John Politis, Kerry Hancock, Jo A Douglass, Paul Leong, Philip Bardin   +4 more
wiley   +1 more source

Topical Adenosine Inhibits Inflammation and Mucus Production in Viral Acute Rhinosinusitis. [PDF]

Laryngoscope, 2023
Waldstein KA, Ganama M, Varga SM, Tilley S, Hua X.   +4 more
europepmc   +1 more source

Prognosis and prediction of antibiotic benefit in adults with clinically diagnosed acute rhinosinusitis: an individual participant data meta-analysis. [PDF]

Diagn Progn Res, 2023
Hoogland J, Takada T, van Smeden M, Rovers MM, de Sutter AI, Merenstein D, Kaiser L, Liira H, Little P, Bucher HC, Moons KGM, Reitsma JB, Venekamp RP.   +12 more
europepmc   +1 more source

Has COVID-19 Changed Pediatric Acute Rhinosinusitis Epidemiology During the First 2 Pandemic Years? [PDF]

Pediatr Infect Dis J, 2023
Hazan I, Ziv O, Marom T, Zloczower E, Pitaro J, Warman M.   +5 more
europepmc   +1 more source

Predictors of Surgical Intervention for Pediatric Acute Rhinosinusitis with Periorbital Infection. [PDF]

J Clin Med, 2022
Wu PW, Lin YL, Lee YS, Chiu CH, Lee TJ, Huang CC.   +5 more
europepmc   +1 more source

Patient Perspectives on the Drivers and Deterrents of Antibiotic Treatment of Acute Rhinosinusitis: a Qualitative Study. [PDF]

J Gen Intern Med, 2023
Smith SS, Caliendo A, Cheng BT, Kern RC, Holl J, Linder JA, Cameron KA.   +6 more
europepmc   +1 more source

Comparative Outcomes of Amoxicillin and Amoxicillin-Clavulanate in the Treatment of Acute Rhinosinusitis in Adults with Comorbidities: A Retrospective Study. [PDF]

Antibiotics (Basel)
Miron RY, Perlov Gavze R, Vered S, Shapiro Ben David S, Liran O.   +4 more
europepmc   +1 more source

The Detection of Bacteria in the Maxillary Sinus Secretion of Patients With Acute Rhinosinusitis Using an Electronic Nose: A Pilot Study. [PDF]

Ann Otol Rhinol Laryngol, 2023
Virtanen J, Roine A, Kontunen A, Karjalainen M, Numminen J, Oksala N, Rautiainen M, Kivekäs I.   +7 more
europepmc   +1 more source

Differential Effects of Benralizumab and Mepolizumab on Pro‐Resolving Mediators

Allergy, Volume 81, Issue 9, Page 3377-3383, September 2026.
Jaime Bernaola, José Antonio Cañas, Álvaro Arranz‐Fragua, José Manuel Rodrigo‐Muñoz, Daniel Rodríguez‐González, Antonio Serrano‐Santiago, Gema Guillén‐Sánchez, Alma Martínez Fernández, Marcela Valverde‐Monge, Diana Betancor, Erwin Javier Pinillos‐Robles, Claudia Rodríguez‐Busto, María Jesús Rodríguez‐Nieto, Joaquín Sastre, Victoria del Pozo   +14 more
wiley   +1 more source